Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Levofloxacin tablet composition and preparation method thereof

A technology of levofloxacin tablet and levofloxacin, which is applied in the field of medicine, can solve the problems such as the decrease of dissolution rate, and achieve the effects of complete dissolution, simple and easy production operation, and good stability

Active Publication Date: 2020-05-08
长春海悦药业股份有限公司
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] CN104288112A discloses a levofloxacin hydrochloride tablet, which adopts talcum powder and stearic acid to add with specific compatibility ratio, shows superior quality controllability in the large-scale production test of levofloxacin hydrochloride tablet, the prepared levofloxacin hydrochloride tablet It has good safety and effectiveness, but it fails to solve the tendency that levofloxacin hydrochloride tablets are easy to aggregate and the dissolution rate decreases during long-term storage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levofloxacin tablet composition and preparation method thereof
  • Levofloxacin tablet composition and preparation method thereof
  • Levofloxacin tablet composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] prescription

[0075]

[0076] Preparation

[0077] (1) Levofloxacin, sorbitol, sodium stearyl fumarate, and croscarmellose sodium are respectively passed through an 80-mesh sieve for subsequent use;

[0078] (2) Dissolve hydroxypropyl cellulose in ethanol to make 5% (w / w) hydroxypropyl cellulose ethanol solution, add oleic acid to dissolve it;

[0079] (3) Levofloxacin, Sorbitol and Croscarmellose Sodium that take recipe quantity are placed in fluidized bed granulator, carry out spray granulation with the binder solution that step (2) makes, dry, Then add sodium stearyl fumarate, mix evenly, and press into tablets to obtain levofloxacin tablets.

Embodiment 2

[0081] prescription

[0082]

[0083] Preparation

[0084] (1) Levofloxacin, microcrystalline cellulose, sodium stearyl fumarate, and sodium carboxymethyl starch are respectively passed through 80 mesh sieves, for subsequent use;

[0085] (2) Dissolve hydroxypropyl cellulose in ethanol to make 5% (w / w) hydroxypropyl cellulose ethanol solution, add oleic acid to dissolve it;

[0086] (3) Levofloxacin, microcrystalline cellulose and carboxymethyl starch sodium taking recipe quantity are placed in fluidized bed granulator, carry out spray granulation with the binding agent solution that step (2) makes, dry, then Add sodium stearyl fumarate, mix evenly, and press into tablets to obtain levofloxacin tablets.

Embodiment 3

[0088] prescription

[0089]

[0090]

[0091] Preparation

[0092] (1) Levofloxacin, microcrystalline cellulose, sodium stearyl fumarate, and croscarmellose sodium are respectively passed through an 80-mesh sieve for subsequent use;

[0093] (2) Dissolve hydroxypropyl cellulose in ethanol to make 5% (w / w) hydroxypropyl cellulose ethanol solution, add oleic acid to dissolve it;

[0094] (3) Levofloxacin, microcrystalline cellulose and croscarmellose sodium taking recipe quantity are placed in fluidized bed granulator, carry out spray granulation with the binding agent solution that step (2) makes, After drying, adding sodium stearyl fumarate, mixing evenly, and pressing into tablets to obtain levofloxacin tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a levofloxacin tablet composition and a preparation method thereof. The pharmaceutical composition contains levofloxacin, a filling agent, a lubricating agent, a disintegrating agent, an adhesive and oleic acid. The product is high in stability, is dissolved completely, and has higher product quality. The product is easy and feasible to produce and operate, and is suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a levofloxacin tablet composition and a preparation method thereof. Background technique [0002] Levofloxac (Levofloxac) is the left-handed optically active L-isomer of ofloxacin, its antibacterial activity is about twice that of ofloxacin, and it has the characteristics of broad antibacterial spectrum and strong antibacterial effect. For most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Serratia, Proteus, Shigella, Salmonella, Citrobacter, Acinetobacter and Pseudomonas aeruginosa Gram-negative bacteria such as Monas, Haemophilus influenzae, and Neisseria gonorrhoeae have strong antibacterial activity. It also has a good antibacterial effect on Gram-positive bacteria such as methicillin-sensitive Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, and hemolytic streptococcus, as well as Legionella, Mycoplasma, and Chlamydia, but it has no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K31/5383A61P31/04
CPCA61K31/5383A61K9/2013A61K9/2009A61P31/04
Inventor 陈南王梅马小涛张岩赵盼盼
Owner 长春海悦药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products